ZEN Stock Overview
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Zentek Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$1.59 |
| 52 Week High | CA$2.30 |
| 52 Week Low | CA$1.30 |
| Beta | 0.84 |
| 1 Month Change | -7.02% |
| 3 Month Change | -0.63% |
| 1 Year Change | -25.00% |
| 3 Year Change | -17.62% |
| 5 Year Change | 297.50% |
| Change since IPO | 160.66% |
Recent News & Updates
Recent updates
Does Zentek (CVE:ZEN) Have A Healthy Balance Sheet?
Jul 09
Is ZEN Graphene Solutions (CVE:ZEN) In A Good Position To Deliver On Growth Plans?
Aug 31We're Keeping An Eye On ZEN Graphene Solutions' (CVE:ZEN) Cash Burn Rate
Mar 11We Think ZEN Graphene Solutions (CVE:ZEN) Needs To Drive Business Growth Carefully
Nov 26Shareholder Returns
| ZEN | CA Medical Equipment | CA Market | |
|---|---|---|---|
| 7D | 5.3% | -0.4% | -2.2% |
| 1Y | -25.0% | -25.0% | 3.9% |
Return vs Industry: ZEN matched the Canadian Medical Equipment industry which returned -24.7% over the past year.
Return vs Market: ZEN underperformed the Canadian Market which returned 4.7% over the past year.
Price Volatility
| ZEN volatility | |
|---|---|
| ZEN Average Weekly Movement | 6.9% |
| Medical Equipment Industry Average Movement | 11.7% |
| Market Average Movement | 9.2% |
| 10% most volatile stocks in CA Market | 18.3% |
| 10% least volatile stocks in CA Market | 3.2% |
Stable Share Price: ZEN's share price has been volatile over the past 3 months.
Volatility Over Time: ZEN's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 29 | Greg Fenton | www.zentek.com |
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound.
Zentek Ltd. Fundamentals Summary
| ZEN fundamental statistics | |
|---|---|
| Market cap | CA$166.35m |
| Earnings (TTM) | -CA$11.98m |
| Revenue (TTM) | CA$33.61k |
4,770x
P/S Ratio-13.4x
P/E RatioIs ZEN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZEN income statement (TTM) | |
|---|---|
| Revenue | CA$33.61k |
| Cost of Revenue | CA$316.44k |
| Gross Profit | -CA$282.83k |
| Other Expenses | CA$11.69m |
| Earnings | -CA$11.98m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.12 |
| Gross Margin | -841.52% |
| Net Profit Margin | -35,637.65% |
| Debt/Equity Ratio | 3.4% |
How did ZEN perform over the long term?
See historical performance and comparison